Researchers who study trends in illicit drug use are concerned that sales of a potent class of synthetic opioids called ...

(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain medication that’s just been approved by the FDA. Suzetrigine is the first ...

The opioid epidemic has affected hospitals, both clinically and financially, for almost 30 years. More than1,000 acute care hospitals will receive a share of $700 million as part of the settlement of ...

Llano police have issued a warning following three overdoses in the past month linked to a potent synthetic drug, potentially ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...

The U.S. drug screening market size is calculated at USD 2.79 billion in 2025 and is expected to reach around USD 3.84 ...